Diffusion and Use of Genomic Innovations in Health and Medicine Workshop Summary (2008) / Chapter Skim
Currently Skimming:
Appendix B: Biographical Sketches of the Workshop Speakers
Appendix B: Biographical Sketches of the Workshop Speakers
Pages 93-100
The Chapter Skim interface presents what we've algorithmically identified as the most significant single chunk of text within every page in the chapter.
Select key terms on the right to highlight them within pages of the chapter.
From page 93... ...
Agency for International Development team providing technical assistance to the Hungarian government on building evidence-based medicine capacity in the national health insurance system. She is a member of the Institute of Medicine Forum on Drug Discovery Translation and Development, and the Steering Committee of the Chicago-Area DEcIDE Research Center and the National Business Group on Health Committee on Evidence-Based Benefit Design.
|
From page 94... ...
He has served on many expert panels using evidencebased methods to develop clinical guidelines, including chairmanship of the United States Preventive Services Task Force, co-chair of the otitis media panel convened by the Agency for Health Care Policy and Research, chair of the CDC STD Treatment Guidelines panel, member of the AMA/CDC panel producing Guidelines for Adolescent Preventive Services, member of the Institute of Medicine's Immunization Safety Review Committee, and chair of the Institute of Medicine's Committee on the Treatment of Posttraumatic Stress Disorder. He currently chairs the CDC's panel on Evaluation of Genomic Applications in Practice and Prevention.
|
From page 95... ...
Former director of the Duke Clinical Research Institute, he became head of the Duke Translational Medicine Institute in 2006. A native of South Carolina, Califf graduated from Duke University, summa cum laude and Phi Beta Kappa, in 1973 and from the Duke University School of Medicine in 1978, where he was selected for Alpha Omega Alpha.
|
From page 96... ...
He was lead author of a recent report for Health Canada on international developments in the regulation of pharmacogenomics and a briefing for the Human Genetics Commission on the regulation of commercial genetic testing services in the United Kingdom. He participated in the drafting of the OECD's guidelines on quality assurance for molecular genetic testing.
|
From page 97... ...
Dr Marshall is a co-investigator on a recently submitted NCI Program Project Grant proposal on Personalized Medicine for Colorectal and Breast Cancer, a grant from the Blue Shield of California Foundation on the policy challenges for personalized medicine, and a grant from Genome Canada on Genome-Specific Approaches to Therapy in Childhood (GATC)
|
From page 98... ...
Dr. Tunis supervised the development of national coverage policies, quality standards for Medicare and Medicaid providers; quality measurement and public reporting initiatives, and the Quality Improvement Organization program.
|
From page 99... ...
He is board certified in Internal Medicine and holds adjunct faculty positions at Johns Hopkins and Stanford University School of Medicine.
|
Key Terms
This material may be derived from roughly machine-read images, and so is provided only to facilitate research.
More
information on Chapter Skim is available.